Global biopesticide makers are now treating the United States and Brazil as their two priority growth markets, according to an analysis published this week by the Latin American agribusiness outlet AgroLatam.

The brief, headlined "Biopesticides: Why the U.S. and Brazil Are Becoming Key Markets for Global Manufacturers," frames both countries — by far the Western Hemisphere's two largest crop-input consumers — as the destinations where multinational suppliers are concentrating product registrations, distribution agreements, and field-development staff.

What does this change for input programs?

For U.S. and Brazilian row-crop operations, the practical question is whether more biological products will reach the spray schedule. Biopesticides, which include microbial agents, biochemical extracts, and plant-incorporated protectants, generally move through shorter regulatory pathways than conventional chemistry in the United States. The EPA's Biopesticides and Pollution Prevention Division has overseen reviews for these products for more than three decades, while conventional pesticides wait longer for clearance. In Brazil, the Ministry of Agriculture, Livestock and Supply (MAPA) has approved an expanding roster of biological agents over the past ten years, a pace international suppliers are using to enter the market faster than they can in the European Union or much of Asia.

Why these two markets

Both countries combine large row-crop acreage with high pesticide use intensity. U.S. corn and soybean programs consume well over 100 million treated acres annually, and Brazilian soybean, sugarcane, and cotton expansion has lifted pesticide demand steadily since the early 2000s as acreage pushed into the Cerrado. Biopesticides are typically positioned as resistance-management tools or residue-friendly alternatives, not full replacements for synthetic chemistry. That positioning is precisely why incumbents and startups alike are watching both markets.

What the report doesn't disclose

AgroLatam's item does not include dollar figures, tonnage data, or named manufacturers. Standard industry sizing for the global biopesticide market is inconsistent: methodologies differ on whether to count microbials, biochemicals, semiochemicals, and plant-incorporated protectants, and reporting windows rarely align across firms. Readers comparing estimates from consultancy reports, company filings, and trade publications will see double-digit percentage-point gaps depending on the source. Treat any single market estimate as a starting point, not a verdict.

Where public data falls short

Most public biopesticide data tracks registrations rather than on-farm use. A product listed in EPA's database does not equal pounds applied in a given season — grower adoption, dealer stocking, and tank-mix compatibility all intervene. The same gap exists in Brazil, where MAPA publishes approved products but not treated area. Until either regulator or a USDA-style treated-acre survey catches up, the strongest demand signal is what suppliers themselves are doing: hiring field staff, signing distribution pacts, and pricing biologicals against synthetic alternatives.

What to watch next

The forward signal from the AgroLatam analysis: expect more biological registrations in 2025 and beyond, more partnerships between multinational agrichemical firms and biological specialists, and more shelf competition for synthetic products. Growers who ask sharper questions about per-acre cost, mode-of-action rotation, and resistance management will see more options land in their dealers' catalogs.